EUVIMEDEUVIMED entdecken
Open Access

CXCR4 signaling determines the fate of hematopoietic multipotent progenitors by stimulating mTOR activity and mitochondrial metabolism

Vincent Rondeau iD, Maria Kalogeraki, Lilian Roland iD, Zeina Abou Nader, Vanessa Gourhand, Amélie Bonaud iD, Julia Lemos, Mélanie Khamyath iD, Clémentine Moulin, Bérénice Schell iD, Marc Delord iD, Ghislain Bidaut iD und 16 weitere

Science Signaling · 2024

DOI: 10.1126/scisignal.adl5100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Signaling, 2024. Verfasst von Vincent Rondeau und 27 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Mitochondria, Signal Transduction, Receptors, CXCR4. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Both cell-intrinsic and niche-derived, cell-extrinsic cues drive the specification of hematopoietic multipotent progenitors (MPPs) in the bone marrow, which comprise multipotent MPP1 cells and lineage-restricted MPP2, MPP3, and MPP4 subsets. Patients with WHIM syndrome, a rare congenital immunodeficiency caused by mutations that prevent desensitization of the chemokine receptor CXCR4, have an excess of myeloid cells in the bone marrow. Here, we investigated the effects of increased CXCR4 signaling on the localization and fate of MPPs. Knock-in mice bearing a WHIM syndrome–associated CXCR4 mutation ( CXCR4 1013 ) phenocopied the myeloid skewing of bone marrow in patients. Whereas MPP4 cells in wild-type mice differentiated into lymphoid cells, MPP4s in CXCR4 1013 knock-in mice differentiated into myeloid cells. This myeloid rewiring of MPP4s in CXCR4 1013 knock-in mice was associated with enhanced signaling mediated by the kinase mTOR and increased oxidative phosphorylation (OXPHOS). MPP4s also localized further from arterioles in the bone marrow of knock-in mice compared with wild-type mice, suggesting that the loss of extrinsic cues from the perivascular niche may also contribute to their myeloid skewing. Chronic treatment with the CXCR4 antagonist AMD3100 or the mTOR inhibitor rapamycin restored the lymphoid potential of MPP4s in knock-in mice. Thus, CXCR4 desensitization drives the lymphoid potential of MPP4 cells by dampening the mTOR-dependent metabolic changes that promote myeloid differentiation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TOR Serine-Threonine KinasesMitochondriaSignal TransductionReceptors, CXCR4Hematopoietic Stem CellsPrimary Immunodeficiency DiseasesAnimalsMiceHumansMultipotent Stem CellsCell DifferentiationImmunologic Deficiency SyndromesMutationOxidative PhosphorylationGene Knock-In TechniquesMice, Inbred C57BLWarts

Substanzen

TOR Serine-Threonine KinasesReceptors, CXCR4mTOR protein, mouseCXCR4 protein, mouse

Autor:innen und Institutionen

  • Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.
  • OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France.
  • Direction à la Recherche Clinique et à l'Innovation, Centre Hospitalier de Versailles, Le Chesnay, France.
  • Aix-Marseille Univ, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France.
  • INSERM U1279, Gustave Roussy Cancer Center, Université Paris Saclay, Villejuif, France.
  • Centre Méditerranéen de Médecine Moléculaire, INSERM U1065, Nice, France.

ORCID-Profile: Vincent Rondeau, Lilian Roland, Amélie Bonaud, Mélanie Khamyath, Bérénice Schell, Marc Delord, Ghislain Bidaut, Séverine Lecourt, Christelle Freitas, Nathalie Mazure, David H McDermott, Niclas Setterblad, Nicolas Dulphy, Françoise Bachelerie, Michel Aurrand-Lions, Daniel Stockholm, Camille Lobry, Philip M Murphy, Karl Balabanian

Förderung

  • Intramural NIH HHS

Zitieren

APA

Rondeau, V., Kalogeraki, M., Roland, L., Nader, Z. A., Gourhand, V., Bonaud, A., Lemos, J., Khamyath, M., Moulin, C., Schell, B., Delord, M., Bidaut, G., Lecourt, S., Freitas, C., Anginot, A., Mazure, N., McDermott, D. H., Parietti, V., Setterblad, N., …, & Balabanian, K. (2024). CXCR4 signaling determines the fate of hematopoietic multipotent progenitors by stimulating mTOR activity and mitochondrial metabolism. Science Signaling. https://doi.org/10.1126/scisignal.adl5100

Vancouver

Rondeau V, Kalogeraki M, Roland L, Nader ZA, Gourhand V, Bonaud A, et al. CXCR4 signaling determines the fate of hematopoietic multipotent progenitors by stimulating mTOR activity and mitochondrial metabolism. Science Signaling. 2024. doi:10.1126/scisignal.adl5100

BibTeX
@article{Rondeau2024,
  author = {Rondeau, Vincent and Kalogeraki, Maria and Roland, Lilian and Nader, Zeina Abou and Gourhand, Vanessa and Bonaud, Amélie and Lemos, Julia and Khamyath, Mélanie and Moulin, Clémentine and Schell, Bérénice and Delord, Marc and Bidaut, Ghislain and Lecourt, Séverine and Freitas, Christelle and Anginot, Adrienne and Mazure, Nathalie and McDermott, David H and Parietti, Véronique and Setterblad, Niclas and Dulphy, Nicolas and Bachelerie, Françoise and Aurrand-Lions, Michel and Stockholm, Daniel and Lobry, Camille and Murphy, Philip M and Espéli, Marion and Mancini, Stéphane J C and Balabanian, Karl},
  title = {CXCR4 signaling determines the fate of hematopoietic multipotent progenitors by stimulating mTOR activity and mitochondrial metabolism},
  journal = {Science Signaling},
  year = {2024},
  doi = {10.1126/scisignal.adl5100}
}
Kostenlos starten →